ProCE Banner Activity

Clinical Case Studies in Diagnostics and Management of Clostridioides difficile Infection (CDI)

Slideset Download
Comprehensive slideset featuring data on key concepts in CDI management, including epidemiology, pathophysiology, burden of disease, diagnostics, and optimizing treatment regimens to minimize the risk for recurrence.

Released: February 14, 2022

Expiration: February 13, 2023

Share

Faculty

Teena Chopra

Teena Chopra, MD, MPH

Professor, Infectious Diseases
Wayne State University
Corporate Medical Director
Infection Prevention
Hospital Epidemiology
Detroit Medical Center
Detroit, Michigan

Paul Feuerstadt

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine
Attending Gastroenterologist
Department of Gastroenterology
Yale University School of Medicine
PACT-Gastroenterology Center
Hamden, Connecticut

Kevin Garey

Kevin Garey, PharmD, MS

Professor and Chair
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
Houston, Texas

Sahil Khanna

Sahil Khanna, MBBS, MS, FACG, AGAF

Professor of Medicine 
Division of Gastroenterology and Hepatology
Mayo Clinic
Rochester, Minnesota

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Teena Chopra, MD, MPH

Professor, Infectious Diseases
Wayne State University
Corporate Medical Director
Infection Prevention
Hospital Epidemiology
Detroit Medical Center
Detroit, Michigan

Teena Chopra, MD, MPH, has disclosed that she has received funds for research support from Cepheid and Ferring; has received consulting fees from Cepheid, Ferring, Merck, Pfizer, and Shionogi; and has received fees for non-CME services from Abbvie, Cepheid, Ferring, Pfizer, and Shionogi.

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine
Attending Gastroenterologist
Department of Gastroenterology
Yale University School of Medicine
PACT-Gastroenterology Center
Hamden, Connecticut

Paul Feuerstadt MD, FACG, AGAF, has disclosed that he has received fees for speaker’s bureau participation from Ferring Pharmaceuticals, Merck, and Takeda; consulting fees from Ferring Pharmaceuticals; and fees for advisory board participation from Ferring Pharmaceuticals, Seres Therapeutics, and Takeda Pharmaceuticals.

Kevin Garey, PharmD, MS

Professor and Chair
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
Houston, Texas

Kevin Garey, PharmD, MS, has disclosed that he has received funds for research support from Acurx, Paratek, Seres Therapeutics, and Summit.

Sahil Khanna, MBBS, MS, FACG, AGAF

Professor of Medicine 
Division of Gastroenterology and Hepatology
Mayo Clinic
Rochester, Minnesota

Sahil Khanna, MBBS, MS, FACG, has disclosed that he has received consulting fees from Jetson, Immuron, Niche, ProBioTech, and Shire/Takeda and funds for research support from Finch, Pfizer, Seres Therapeutics, Rebiotix/Ferring, and Vedanta.